Clinical Trial: Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge

U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07059767) titled 'Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge' on June 27.

Brief Summary: A Phase IIa trial in participants with asthma to evaluate the impact of intranasal ETH47 on the development of asthma-related symptoms following rhinovirus challenge

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Asthma (Diagnosis)

Intervention: DRUG: ETH47

single intranasal dose of ETH47

DRUG: Placebo

single intranasal dose of placebo

Recruitment Status: RECRUITING

Sponsor: Ethris GmbH

Disclaimer: Curated by HT Syndicat...